Multimodal prehabilitation in a patient with right colon cancer, frailty and severe sarcopenia: a case report

Background. The high frequency of frailty and sarcopenia in patients with cancer led to the development of «prehabilitation» concept. multimodal prehabilitation includes physical training, nutritional and psychological support before anticancer treatment.

Aim. we aim to present the results of treatment of a patient with frailty and severe sarcopenia who underwent a multimodal prehabilitation program before surgery for colorectal cancer.

Materials and methods. A 81-year-old woman with colon cancer was diagnosed with frailty and severe sarcopenia. The patient underwent a multimodal prehabilitation for 12 days prior to surgery, which included nutritional and psychological support as well as a supervised physical exercise program based on nordic walking.

Results. The patient gained weight. Also, she increased grip strength and gait speed. The postoperative period went uneventfully and the patient was discharged home 7 days after surgery.

Conclusions. multimodal prehabilitation is a potentially beneficial option in sarcopenic patients with frailty and colon cancer who need surgery.

1. Tkacheva O.N., Kotovskaya Yu.V., Runikhina N.K. et al. Clinical recommendations for frailty. Rossijskij zhurnal geriatricheskoj mediciny = Russian journal of geriatric medicine 2020(1):11–46. (In Russ.). DOI: 10.37586/2686-8636-1-2020-11-46

2. Malignant neoplasms In Russ.a in 2020 (morbidity and mortality). Ed. by A.D. Kaprin, V.V. Starinsky, A.O. Shakhzadova. Moscow, 2021. (In Russ.).

3. Handforth C., Clegg A., Young C. et al. The prevalence and outcomes of frailty in older cancer patients: a systematic review. Ann Oncol 2015;26(6):1091–101. DOI: 10.1093/annonc/mdu540

4. Dotan E., Walter L.C., Browner I.S. et al. NCCN guidelines insights: older adult oncology, version 1.2021. J Natl Compr Canc NETw 2021;19(9):1006–19. DOI: 10.6004/jnccn.2021.0043

5. Pallis A.G., Gridelli C., Wedding U. et al. Management of elderly patients with NSCLC; updated expert’s opinion paper: EORTC Elderly Task Force, Lung Cancer Group and International Society for Geriatric Oncology. Ann Oncol 2014;25(7):1270–83. DOI: 10.1093/annonc/mdu022

6. Mohile S.G., Dale W., Somerfield M.R. et al. Practical assessment and management of vulnerabilities in older patients receiving chemotherapy: ASCO guideline for geriatric oncology. J Clin Oncol 2018;36(22):2326–47. DOI: 10.1200/JCO.2018.78.8687

7. Faller J.W., Pereira D.N., de Souza S. et al. Instruments for the detection of frailty syndrome in older adults: a systematic review. PLOS One 2019;14(4):55–64. DOI: 10.1371/journal.pone.0216166

8. Tkacheva O.N., Runikhina N.K., Ostapenko V.S. Validation of a questionnaire for screening the syndrome of frailty in outpatient practice. Uspekhi gerontologii = Advances in Gerontology 2017;30(2):236–42 (In Russ.).

9. Gulasingam P., Haq R., Mascarenhas Johnson A. et al. Using implementation science to promote the use of the G8 screening tool in geriatric oncology. J Am Geriatr Soc 2019;67(5):898–904. DOI: 10.1111/jgs.15920

10. Owusu C., Koroukian S.M., Schluchter M. et al. Screening older cancer patients for a Comprehensive Geriatric Assessment: a comparison of three instruments. J Geriatr Oncol 2011;2(2):121–9. DOI: 10.1016/j.jgo.2010.12.002. PMID: 21927633

11. Gomes F., Lorigan P., Woolley S. et al. A prospective cohort study on the safety of checkpoint inhibitors in older cancer patients – the ELDERS study. ESMO Open 2021;6(1):100042. DOI: 10.1016/j.esmoop.2020.100042

12. Luciani A., Biganzoli L., Colloca G. et al. Estimating the risk of chemotherapy toxicity in older patients with cancer: the role of the Vulnerable Elders Survey-13 (VES-13). J Geriatr Oncol 2015;6(4):272–9. DOI: 10.1016/j.jgo.2015.02.005

13. Trejo-Avila M., Bozada-Gutiérrez K., Valenzuela-Salazar C. et al. Sarcopenia predicts worse postoperative outcomes and decreased survival rates in patients with colorectal cancer: a systematic review and meta-analysis. Int J Colorectal Dis 2021;36(6):1077–96. DOI: 10.1007/s00384-021-03839-4

14. Chen S., Ma T., Cui W. et al. Frailty and long-term survival of patients with colorectal cancer: a meta-analysis. Aging Clin Exp Res 2022;34(7):1485–94. DOI: 10.1007/s40520021-02072-x

15. Minnella E.M., Carli F. Prehabilitation and functional recovery for colorectal cancer patients. Eur J Surg Oncol 2018;44(7):919–26. DOI: 10.1016/j.ejso.2018.04.016

16. Malignant neoplasms of the colon and rectosigmoid department. Clinical guidelines, 2020. Available at: https://oncologyassociation.ru/wp-content/uploads/2020/09/zno_obodochnoj_kishki.pdf. (In Russ.)

17. Prado C.M., Lieffers J.R., McCargar L.J. et al. Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a populationbased study. Lancet Oncol 2008;9(7):629–35. DOI: 10.1016/S14702045(08)70153-0

18. Martin L., Birdsell L., Macdonald N. et al. Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index. J Clin Oncol 2013;31(12):1539–47. DOI: 10.1200/JCO.2012.45.2722

19. Cruz-Jentoft A.J., Bahat G., Bauer J. et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing 2019;48(1):16–31. DOI: 10.1093/ageing/afy169

20. Nurmukhametov R.A., Dikova T.S., Lyadov V.K. et al. Multimodal prehabilitation in patients with colorectal cancer: a systematic review. Prakticheskaya onkologiya = Practical oncology 2022;23(3):187–94. (In Russ.)